Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles.
about
The immunological synapse: the gateway to the HIV reservoirUnderstanding the process of envelope glycoprotein incorporation into virions in simian and feline immunodeficiency virusesThe role of matrix in HIV-1 envelope glycoprotein incorporationLipids and membrane microdomains in HIV-1 replicationC-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic.The cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein gp41 harbors lipid raft association determinantsEvidence that Gag facilitates HIV-1 envelope association both in GPI-enriched plasma membrane and detergent resistant membranes and facilitates envelope incorporation onto virions in primary CD4+ T cells.Wild-type-like viral replication potential of human immunodeficiency virus type 1 envelope mutants lacking palmitoylation signals.Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.The Role of Lipids in Retrovirus Replication.Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly.The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.Gag regulates association of human immunodeficiency virus type 1 envelope with detergent-resistant membranes.Relationships between plasma membrane microdomains and HIV-1 assemblyAn alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence.Human Ubc9 is involved in intracellular HIV-1 Env stability after trafficking out of the trans-Golgi network in a Gag dependent manner.HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.Respiratory syncytial virus F envelope protein associates with lipid rafts without a requirement for other virus proteins.Effects of stabilization of the gp41 cytoplasmic domain on fusion activity and infectivity of SIVmac239.Evidence against extracellular exposure of a highly immunogenic region in the C-terminal domain of the simian immunodeficiency virus gp41 transmembrane proteinIncorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusionCharacterization and role of lentivirus-associated host proteins.Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection.Importance of conserved cysteine residues in the coronavirus envelope protein.Lipid rafts, detergent-resistant membranes, and raft targeting signals.The frantic play of the concealed HIV envelope cytoplasmic tail.Identification of the LWYIK motif located in the human immunodeficiency virus type 1 transmembrane gp41 protein as a distinct determinant for viral infectionRoles of the interactions between Env and Gag proteins in the HIV-1 replication cycle.The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle.T cell polarization at the virological synapse.The cholesterol-binding motif of the HIV-1 glycoprotein gp41 regulates lateral sorting and oligomerization.Unraveling the role of membrane microdomains during microbial infections.Membrane raft association of the Vpu protein of human immunodeficiency virus type 1 correlates with enhanced virus release.Function of membrane rafts in viral lifecycles and host cellular responseThe six-helix bundle of human immunodeficiency virus Env controls pore formation and enlargement and is initiated at residues proximal to the hairpin turnThe Myxobacterial Metabolite Soraphen A Inhibits HIV-1 by Reducing Virus Production and Altering Virion Composition.Development of a Moloney murine leukemia virus-based pseudotype anti-HIV assay suitable for accurate and rapid evaluation of HIV entry inhibitors.The transmembrane oligomers of coronavirus protein E.Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1.
P2860
Q27002959-29F3B775-7933-4034-8CA6-BF96810D7E48Q27021655-960F0744-B938-47C8-8371-14EBDC6873E9Q27023106-268EAF01-076D-4742-A280-22D5CC8C4254Q27489393-544FE155-1DB4-41A0-9C53-80487C68C7CFQ30422545-FCF907FD-BCC1-4A01-B77B-64FFBA651068Q33558652-F5B447AE-2B8A-497E-9BAD-DB88D1E7D86DQ33645234-8FB3C238-811A-4098-9243-0F8791F90915Q33843329-04E79F38-407E-45CC-A426-3DB8F0351C24Q33984243-AC716F0B-9B33-41A4-A239-E1F78193E15BQ34080779-770F7282-9C24-4210-BC96-C2115FBD35E7Q34092725-E6C2B0D7-3B67-4A01-AEF2-038CC027F59FQ34306883-4AC797E4-78ED-47EE-95D7-3E88CEC86022Q34648092-362E3C82-600E-4735-A943-0405AE0B94BBQ34666503-7D17AE86-4111-4298-BEBA-6484D489CFBAQ34763384-34C4A599-7173-401C-B304-D0B5AA1BE3B5Q34828531-303D5776-06E2-4359-957B-F2D8FDCC88EAQ35113720-98E5624A-73BC-4956-81B7-F9BE07B3E1E3Q35185963-78351AC3-E601-4DC3-AD59-2BFF2614F52AQ35508285-2368ADE7-DDC8-40A9-9081-740286EE4382Q35665722-71347063-12B4-4C7E-97FE-8179AEB3E789Q36099235-74346CB7-E6B4-4069-83BD-A1CC46BCFDBEQ36303032-5C0A4EA7-D5CD-4306-A107-962CD94A812EQ36412305-2E9FDCFB-A8C6-40CD-98BB-F2839BDF5190Q36459268-78FE359E-29E4-4756-82FD-31E391B70524Q36484065-E83061D0-6011-4782-A1FE-9588DBAB78E4Q36659985-6F30BE83-4667-4333-862A-84648E8B8DC5Q36940646-306C55B8-3308-42DC-A723-4CD76B6E9259Q37033417-D81EBD57-0323-46A9-A261-D5083D17CEBEQ37192594-FDA83B23-84FF-465E-9177-EDE1E11E5C5FQ37747105-DB2759AE-0ED6-4676-A8B6-70ED5A8AE0C4Q37945207-E20D0D0E-1B52-4E1B-90EE-5832A5C4704CQ38993416-DA2AC541-870C-4D8A-B1D5-6B8981FC3905Q39169754-2DE3A2D8-9640-4CAF-8464-75F9E1F5F04BQ39649986-3E64DB30-9C98-4D28-8542-A1BCA1E4BB96Q39724559-016DE59E-1C44-45F3-8E92-E2F37A737858Q39822146-A1CD462B-58E3-4C8E-A19F-32EFB9ABC23EQ40190121-29E8AFE8-B3CF-45E7-8EC8-41CCB1F9B142Q40255176-765061C3-5236-4E06-9A1E-5BBF5B71E6A0Q40316333-C38D82C8-D8E4-45EB-8DE2-92EF0E87CF7BQ41819754-702DF873-72EA-41C8-A522-AE63341FB438
P2860
Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Human immunodeficiency virus t ...... onto budding virus particles.
@en
type
label
Human immunodeficiency virus t ...... onto budding virus particles.
@en
prefLabel
Human immunodeficiency virus t ...... onto budding virus particles.
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus t ...... onto budding virus particles.
@en
P2093
Jayanta Bhattacharya
Paul J Peters
Paul R Clapham
P2860
P304
P356
10.1128/JVI.78.10.5500-5506.2004
P407
P577
2004-05-01T00:00:00Z